Todos Medical Enters into Joint Venture Agreement with Amarantus to develop Alzheimer’s Blood Diagnostic LymPro Test 2.0
December 03, 2018 08:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel and NEW YORK, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Todos Medical to Present Scientific Abstract at the Upcoming San Antonio Breast Cancer Symposium (SABCS)
November 29, 2018 08:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Todos Medical, Ltd. Announces Additional Patent Issuance Covering the Use of IR Spectrum of Blood Plasma For Indicating the Presence of Breast Cancer
October 17, 2018 08:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Oct. 17, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early...
Todos Medical, Ltd. Signs Non-Binding Memorandum of Understanding with Orot+ for Distribution Rights of its Breast Cancer Screening Tests in Romania and Austria
September 13, 2018 08:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Todos Medical, Ltd. Appoints Herman Weiss, MD MBA as New Chief Executive Officer
July 31, 2018 16:03 ET
|
Todos Medical Ltd.
REHOVOT, Israel, July 31, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) (http://www.Todosmedical.com) today announced that its Board of Directors has appointed Herman Weiss, MD MBA as...
Todos Medical reports on results of clinical trials for its blood test for breast cancer screening (TM - B1) conducted at Kaplan Hospital in Rehovot, Israel
March 22, 2018 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTC Pink:TOMDF) (http://www.Todosmedical.com) today announced the results of a clinical trial recently completed at Kaplan...
U.S. Patent and Trademark Office has granted to Todos Medical two additional patents
February 12, 2018 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 12, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB:TOMDF) (www.todosmedical.com), a clinical-stage in-vitro diagnostics company focused on the development of blood...
Mr. David Ben Naim, CPA, MBA Joins Todos Medical as Chief Financial Officer
February 06, 2018 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Todos Medical, Ltd. Inc. (OTCQB:TOMDF) (www.todosmedical.com), a clinical-stage in-vitro diagnostics company focused on the development of blood...
Pink-tober Isn't Just for Breast Health Anymore
September 24, 2014 10:20 ET
|
Colon Cancer Alliance
WASHINGTON, Sept. 24, 2014 (GLOBE NEWSWIRE) -- It's no secret; the color pink dominates during October. Breast cancer awareness efforts have changed the way the community responds to conversations...
Atossa Genetics Announces Nationwide Agreement With Network Provider HealthSmart
June 17, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 17, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, has entered into a contractual agreement with HealthSmart, a Preferred Provider...